Amy Penticoff, MBA

Vice President, Technical Operations

Amy brings 30 years of product development, manufacturing, quality control, regulatory strategy and supply chain of small molecule and biologic drugs to Amphivena. Most recently she was a senior member of the Technical Operations team at ARMO BioSciences (now Eli Lilly), where she was responsible for Pegilodecakin and anti-PD-1 mAb drug product manufacture in support of the company’s clinical trials, as well as the development of the Pegilodecakin prefilled syringe. Following ARMO’s acquisition, Ms Penticoff oversaw the transfer of the product manufacturing technology from ARMO to Eli Lilly. Prior to ARMO, she served as Sr. Director of supply chain at Intarcia Therapeutics where she worked on a peptide based implantable product for the treatment of diabetes and development of a sterile implantation kit intended for commercialization. Before that, she was Director of Pharmaceutical Sciences at NeurogesX, Inc., supporting the development and commercialization of the QUTENZA® Dermal Patch. She also held various technical and managerial roles at SRI International, AP Pharma (now Heron Therapeutics), Oral-B Laboratories (now Gillette), Clorox and Dow Corning (now DowDupont). Ms. Penticoff holds a B.S. in Chemistry from the University of Illinois, Urbana-Champaign and an MBA from Pepperdine University, CA and holds patents in formulation and manufacturing.

Leadership

Jeanmarie Guenot

Jeanmarie Guenot, Ph.D.

Founder, President & CEO

Victoria Smith

Victoria Smith, Ph.D.

Chief Scientific Officer

Patrick Chun

Patrick Chun, M.D.

Vice President

Clinical Development

Amy Penticoff

Amy penticoff, MBA

Vice President

Technical Operations